In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Albireo Pharma Inc. (NASDAQ:ALBO) reported that Mfp Investors Llc. has picked up 1,686,628 of common stock as of 2017-06-05.
The acquisition brings the aggregate amount owned by Mfp Investors Llc. to a total of 1,686,628 representing less than 9.9% stake in the company.
For those not familiar with the company, Papa Murphy’s Holdings, Inc. is a holding company. The Company, together with its subsidiaries, is a franchisor and operator of the Take ‘N’ Bake pizza chain in the United States. The Company franchises the right to operate Take ‘N’ Bake pizza franchises and operates Take ‘N’ Bake pizza stores owned by the Company. The Company operates through three segments: Domestic Company Stores, Domestic Franchise and International. Its Domestic Franchise segment consists of its domestic franchised stores, which represent its system-wide stores and derives its revenues from franchise and development fees and the collection of franchise royalties. The Domestic Company Stores segment consists of its Company-owned stores in the United States and derives its revenues from retail sales of pizza and side items to the general public. Its International segment consists of its stores outside of the United States, all of which are franchised and derives its revenues from franchise and development fees.
A glance at Albireo Pharma Inc. (NASDAQ:ALBO)’s key stats reveals a current market capitalization of 76.77 Million based on 16.95 Million shares outstanding and a price at last close of $4.70 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-29, Tipp picked up 4,100 at a purchase price of $4.84. This brings their total holding to 34,223 as of the date of the filing.
On the sell side, the most recent transaction saw Kim unload 6,314 shares at a sale price of $17.55. This brings their total holding to 11,071.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Albireo Pharma Inc. (NASDAQ:ALBO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.